Sodium voltage-gated channel alpha subunit 9
Sodium Voltage-Gated Channel Alpha Subunit 9[edit]
The sodium voltage-gated channel alpha subunit 9, also known as Nav1.7, is a protein that in humans is encoded by the SCN9A gene. This protein is a part of the voltage-gated sodium channel family, which is crucial for the initiation and propagation of action potentials in neurons.
Structure[edit]
Nav1.7 is a transmembrane protein that forms a pore through which sodium ions can pass. It is composed of four homologous domains, each containing six transmembrane segments. The fourth segment in each domain acts as the voltage sensor, while the loop between the fifth and sixth segments forms the ion-conducting pore.
Function[edit]
Nav1.7 channels are primarily expressed in the peripheral nervous system, particularly in nociceptors, which are sensory neurons responsible for the detection of painful stimuli. These channels play a critical role in the generation and conduction of action potentials in response to noxious stimuli, thus contributing to the sensation of pain.
Clinical Significance[edit]
Mutations in the SCN9A gene can lead to a variety of pain disorders. Gain-of-function mutations are associated with conditions such as primary erythromelalgia and paroxysmal extreme pain disorder, where patients experience episodes of severe pain. Conversely, loss-of-function mutations can result in congenital insensitivity to pain, a condition where individuals cannot feel pain, leading to an increased risk of injury.
Pharmacology[edit]
Nav1.7 is a target for the development of new analgesic drugs. Selective blockers of this channel are being investigated as potential treatments for chronic pain conditions, as they may provide pain relief without the side effects associated with traditional pain medications like opioids.
Research[edit]
Ongoing research is focused on understanding the precise mechanisms by which Nav1.7 contributes to pain signaling and how it can be modulated to treat pain. Structural studies, such as those using cryo-electron microscopy, have provided detailed insights into the channel's architecture, aiding in the design of specific inhibitors.
